VCLN vs. BBC

Last updated Jun 23, 2026

VCLN (Virtus Duff & Phelps Clean Energy ETF) and BBC (Virtus LifeSci Biotech Clinical Trials ETF) are both exchange-traded funds - VCLN is a Sustainable fund actively managed by Virtus Investment Partners, while BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index. VCLN is actively managed, while BBC is passively managed. Over the past 3 years, VCLN returned 19.29%/yr vs 26.34%/yr for BBC. At a 0.45 correlation, their price movements are largely independent. VCLN charges 0.59%/yr vs 0.79%/yr for BBC.

Performance

VCLN vs. BBC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus Duff & Phelps Clean Energy ETF (VCLN) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, VCLN achieves a 29.71% return, which is significantly higher than BBC's 23.79% return.

VCLN

• 1D: 1.65%
• 1M: -3.17%
• YTD: 29.71%
• 6M: 25.66%
• 1Y: 73.69%
• 3Y*: 19.29%
• 5Y*: —
• 10Y*: —

BBC

• 1D: 4.97%
• 1M: 11.76%
• YTD: 23.79%
• 6M: 18.79%
• 1Y: 151.23%
• 3Y*: 26.34%
• 5Y*: -0.15%
• 10Y*: 10.98%

*Multi-year figures are annualized to reflect compound growth (CAGR)

VCLN vs. BBC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
VCLN Virtus Duff & Phelps Clean Energy ETF	29.71%	55.75%	-6.69%	-17.54%	-7.87%	-5.21%
BBC Virtus LifeSci Biotech Clinical Trials ETF	23.79%	63.77%	-1.11%	-1.80%	-35.13%	-13.62%

Correlation

The correlation between VCLN and BBC is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.22
Correlation (3Y) Calculated over the trailing 3-year period	0.37
Correlation (All Time) Calculated using the full available price history since Aug 4, 2021	0.45

Over the past year, the correlation between VCLN and BBC has dropped to 0.22 - well below their long-term average of 0.45, suggesting their price drivers have been diverging.

VCLN vs. BBC - Sectors Allocation Comparison

Sectors	VCLN	BBC
Industrials	35.0%	-
Utilities	34.9%	-
Energy	18.1%	-
Technology	9.9%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Financial Services	-	-
Healthcare	-	100.0%
Real Estate	-	-

Return for Risk

VCLN vs. BBC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VCLN

VCLN Risk / Return Rank: 80
VCLN Sharpe Ratio Rank: 80
VCLN Sortino Ratio Rank: 74
VCLN Omega Ratio Rank: 68
VCLN Calmar Ratio Rank: 89
VCLN Martin Ratio Rank: 89

BBC

BBC Risk / Return Rank: 94
BBC Sharpe Ratio Rank: 97
BBC Sortino Ratio Rank: 94
BBC Omega Ratio Rank: 90
BBC Calmar Ratio Rank: 97
BBC Martin Ratio Rank: 95

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VCLN vs. BBC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus Duff & Phelps Clean Energy ETF (VCLN) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	VCLN	BBC	Difference
Sharpe ratio: Return per unit of total volatility	2.45	4.20	-1.75
Sortino ratio: Return per unit of downside risk	3.16	4.59	-1.43
Omega ratio: Gain probability vs. loss probability	1.39	1.55	-0.15
Calmar ratio: Return relative to maximum drawdown	5.13	10.08	-4.95
Martin ratio: Return relative to average drawdown	18.99	29.53	-10.55

VCLN vs. BBC - Sharpe Ratio Comparison

The current VCLN Sharpe Ratio is 2.45, which is lower than the BBC Sharpe Ratio of 4.20. The chart below compares the historical Sharpe Ratios of VCLN and BBC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

VCLN vs. BBC - Drawdown Comparison

The maximum VCLN drawdown since its inception was -45.66%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for VCLN and BBC.

Drawdown Indicators

	VCLN	BBC	Difference
Max Drawdown Largest peak-to-trough decline	-45.66%	-76.85%	+31.19%
Max Drawdown (1Y) Largest decline over 1 year	-14.45%	-15.10%	+0.65%
Max Drawdown (3Y) Largest decline over 3 years	-29.25%	-54.45%	+25.20%
Max Drawdown (5Y) Largest decline over 5 years	—	-71.97%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-76.85%	—
Current Drawdown Current decline from peak	-7.87%	-20.54%	+12.67%
Average Drawdown Average peak-to-trough decline	-23.92%	-37.09%	+13.17%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.90%	5.14%	-1.24%

Volatility

VCLN vs. BBC - Volatility Comparison

The current volatility for Virtus Duff & Phelps Clean Energy ETF (VCLN) is 11.49%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 12.13%. This indicates that VCLN experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VCLN	BBC	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.49%	12.13%	-0.64%
Volatility (6M) Calculated over the trailing 6-month period	21.11%	26.75%	-5.64%
Volatility (1Y) Calculated over the trailing 1-year period	30.28%	36.33%	-6.05%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	27.62%	39.51%	-11.89%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.62%	37.79%	-10.17%

VCLN vs. BBC - Expense Ratio Comparison

VCLN has a 0.59% expense ratio, which is lower than BBC's 0.79% expense ratio.

Dividends

VCLN vs. BBC - Dividend Comparison

VCLN's dividend yield for the trailing twelve months is around 1.61%, more than BBC's 1.37% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBC Virtus LifeSci Biotech Clinical Trials ETF	1.37%	1.70%	1.00%	0.34%	0.00%	0.00%	0.00%	0.00%	0.00%	2.09%	0.00%	0.51%
VCLN Virtus Duff & Phelps Clean Energy ETF	1.61%	2.01%	1.16%	1.14%	0.65%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both VCLN and BBC in my portfolio?

VCLN and BBC have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, VCLN or BBC?

BBC has higher volatility (12.13%) compared to VCLN (11.49%). In terms of maximum drawdown, VCLN dropped -45.66% vs BBC's -76.85%.

Which ETF is better, VCLN or BBC?

On 3-year performance, BBC leads with 26.34% vs 19.29% for VCLN. On fees, VCLN is cheaper at 0.59% per year. On volatility, VCLN has been the lower-risk option at 11.49%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, VCLN or BBC?

Over the 3-year period, BBC has performed better with a 26.34% return vs 19.29%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, VCLN or BBC?

VCLN is cheaper with a 0.59% expense ratio, compared with 0.79% for BBC.

Which ETF pays a higher dividend yield, VCLN or BBC?

VCLN has the higher dividend yield at 1.61%, compared with 1.37% for BBC.

What is the main difference between VCLN and BBC?

VCLN is categorized as Sustainable, while BBC is Health & Biotech Equities. Their fees differ too: 0.59% for VCLN and 0.79% for BBC.

Which has better risk-adjusted returns?

BBC currently has the higher Sharpe Ratio (4.20 vs 2.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.